Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4169921
Max Phase: Preclinical
Molecular Formula: C73H133N17O17
Molecular Weight: 1520.97
Molecule Type: Unknown
Associated Items:
ID: ALA4169921
Max Phase: Preclinical
Molecular Formula: C73H133N17O17
Molecular Weight: 1520.97
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCC[C@@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCC)NC(=O)C[C@H](CO)NC(=O)C[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)C[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C[C@H](CCCCN)NC(=O)C[C@@H]1CCCN1C(C)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC
Standard InChI: InChI=1S/C73H133N17O17/c1-12-17-24-48(34-58(77)95)81-68(102)54(28-20-22-32-75)85-70(104)53(27-18-13-2)83-59(96)36-50(41-91)80-63(100)39-56(44(8)14-3)84-64(101)40-78-71(105)65(43(6)7)87-61(98)37-51(42-92)82-69(103)55(29-30-57(76)94)86-72(106)67(46(10)16-5)89-73(107)66(45(9)15-4)88-60(97)35-49(25-19-21-31-74)79-62(99)38-52-26-23-33-90(52)47(11)93/h43-46,48-56,65-67,91-92H,12-42,74-75H2,1-11H3,(H2,76,94)(H2,77,95)(H,78,105)(H,79,99)(H,80,100)(H,81,102)(H,82,103)(H,83,96)(H,84,101)(H,85,104)(H,86,106)(H,87,98)(H,88,97)(H,89,107)/t44-,45-,46-,48-,49-,50+,51+,52-,53-,54-,55-,56-,65-,66-,67-/m0/s1
Standard InChI Key: ALXBWACFDJWUBG-AVLQUFTNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1520.97 | Molecular Weight (Monoisotopic): 1520.0065 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. de Lucio H, Gamo AM, Ruiz-Santaquiteria M, de Castro S, Sánchez-Murcia PA, Toro MA, Gutiérrez KJ, Gago F, Jiménez-Ruiz A, Camarasa MJ, Velázquez S.. (2017) Improved proteolytic stability and potent activity against Leishmania infantum trypanothione reductase of α/β-peptide foldamers conjugated to cell-penetrating peptides., 140 [PMID:29017116] [10.1016/j.ejmech.2017.09.032] |
Source(1):